12/4
10:58 am
bioa
BioAge Labs BGE-102 Phase 1 Trial Shows Potential in Targeting Inflammation in Central Nervous System, Peripheral Tissues [Yahoo! Finance]
Low
Report
BioAge Labs BGE-102 Phase 1 Trial Shows Potential in Targeting Inflammation in Central Nervous System, Peripheral Tissues [Yahoo! Finance]
12/4
09:00 am
bioa
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
High
Report
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
12/4
02:18 am
bioa
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
High
Report
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
12/4
02:13 am
bioa
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
High
Report
New Leqembi-data presented at CTAD 2025 suggests potential to delay disease progression by up to 8.3 years with continued treatment
11/25
06:03 pm
bioa
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Medium
Report
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/25
04:30 pm
bioa
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
Medium
Report
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
11/13
06:51 pm
bioa
Leqembi® approved for IV maintenance treatment in the United Kingdom
Low
Report
Leqembi® approved for IV maintenance treatment in the United Kingdom
11/13
06:50 pm
bioa
Leqembi® approved for IV maintenance treatment in the United Kingdom
Low
Report
Leqembi® approved for IV maintenance treatment in the United Kingdom
11/6/2025
04:45 pm
BIOA
bioage labs, inc.
BEAT
Report
-4.6%
bioage labs, inc.
8/6/2025
04:30 pm
BIOA
bioage labs, inc.
MISS
Report
-0.2%
bioage labs, inc.
12/4
04:30 pm
bioa
Form 144 BioAge Labs, Inc. Filed by: RUBIN PAUL D
Medium
Report
Form 144 BioAge Labs, Inc. Filed by: RUBIN PAUL D
12/4
09:05 am
bioa
Form 8-K BioAge Labs, Inc. For: Dec 04
Medium
Report
Form 8-K BioAge Labs, Inc. For: Dec 04
11/6
04:56 pm
bioa
Form 10-Q BioAge Labs, Inc. For: Sep 30
Medium
Report
Form 10-Q BioAge Labs, Inc. For: Sep 30
11/6
04:50 pm
bioa
Form 8-K BioAge Labs, Inc. For: Nov 06
Low
Report
Form 8-K BioAge Labs, Inc. For: Nov 06
11/5
04:42 pm
bioa
Form S-3/A BioAge Labs, Inc.
Low
Report
Form S-3/A BioAge Labs, Inc.
11/5
04:41 pm
bioa
Form S-3/A BioAge Labs, Inc.
Low
Report
Form S-3/A BioAge Labs, Inc.
10/2
04:35 pm
bioa
Form S-3 BioAge Labs, Inc.
Low
Report
Form S-3 BioAge Labs, Inc.
10/2
04:31 pm
bioa
Form S-3 BioAge Labs, Inc.
Low
Report
Form S-3 BioAge Labs, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register